Search

Search Constraints

You searched for: Author/Creator Lang, John

Search Results

1. Immune globulin subcutaneous, human 20% solution (Xembify®), a new high concentration immunoglobulin product for subcutaneous administration. (March 2020)

2. Safety of elective paediatric surgery during the coronavirus disease 2019 pandemic. (November 2021)

3. Comparison of the liquid and lyophilized formulations of Prolastin®-C for Alpha1-Antitrypsin deficiency: Biochemical characteristics, pharmacokinetics, safety and neoantigenicity in rabbits. (November 2019)